In the News November 29, 2017

The Pink Sheet | Indication “Carve In” Allowed Under Generic Labeling “Carve-Out” Authority, US FDA Says

Marc Scheineson is quoted on a U.S. Food and Drug Administration decision allowing new language in abbreviated new drug applications.
Media Contact
Alex Wolfe
Communications Director

This website uses cookies to improve functionality and performance. For more information, see our Privacy Statement. Additional details for California consumers can be found here.